seviteronel: Clinical Trials

2 trials of seviteronel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow seviteronel: new trials by email Literature Review of seviteronel trials Research Report on seviteronel

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel - Triple Negative Breast Cancer
Phase 1 / Phase 2RecruitingSt Vincent's Hospital, Sydney652022-11-012025-05-15
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)
Seviteronel - Cancer of the Breast, Breast Cancer
Phase 1 / Phase 2CompletedInnocrin Pharmaceutical1752015-08-012019-02-01

Conditions studied

Triple Negative Breast Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)

Sponsors

Innocrin Pharmaceutical (1)  ·  St Vincent's Hospital, Sydney (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

Victoria Brown, BS (1)